Search: WFRF:(Kilani A) >
Availability of hep...
-
Leblebicioglu, HakanDepartment of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University, Medical School, Samsun, Turkey
(author)
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries
- Article/chapterEnglish2018
Publisher, publication year, extent ...
-
Amsterdam, Netherlands :Elsevier,2018
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:oru-63296
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-63296URI
-
https://doi.org/10.1016/j.antiviral.2017.12.001DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
BACKGROUND: Treatment with direct acting antiviral agents (DAAs) has provided sustained virological response rates in >95% of patients with chronic hepatitis C virus (HCV) infection. However treatment is costly and market access, reimbursement and governmental restrictions differ among countries. We aimed to analyze these differences among European and Eurasian countries.METHODS: A survey including 20-item questionnaire was sent to experts in viral hepatitis. Countries were evaluated according to their income categories by the World Bank stratification.RESULTS: Experts from 26 countries responded to the survey. As of May 2016, HCV prevalence was reported as low (≤1%) in Croatia, Czech Republic, Denmark, France, Germany, Hungary, the Netherlands, Portugal, Slovenia, Spain, Sweden, UK; intermediate (1-4%) in Azerbaijan, Bosnia and Herzegovina, Italy, Kosovo, Greece, Kazakhstan, Romania, Russia, Serbia and high in Georgia (6.7%). All countries had national guidelines except Albania, Kosovo, Serbia, Tunisia, and UK. Transient elastography was available in all countries, but reimbursed in 61%. HCV-RNA was reimbursed in 81%. PegIFN/RBV was reimbursed in 54% of the countries. No DAAs were available in four countries: Kazakhstan, Kosovo, Serbia, and Tunisia. In others, at least one DAA combination with either PegIFN/RBV or another DAA was available. In Germany and the Netherlands all DAAs were reimbursed without restrictions: Sofosbuvir and sofosbuvir/ledipasvir were free of charge in Georgia.CONCLUSION: Prevalence of HCV is relatively higher in lower-middle and upper-middle income countries. DAAs are not available or reimbursed in many Eurasia and European countries. Effective screening and access to care are essential for reducing liver-related morbidity and mortality.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Arends, Joop E.Internal Medicine and Infectious Diseases, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands
(author)
-
Ozaras, ResatDepartment of Infectious Diseases and Clinical Microbiology, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey
(author)
-
Corti, GiampaoloInfectious Disease Unit, University of Florence School of Medicine, Florence, Italy
(author)
-
Santos, LurdesInfectious Diseases Service C Hospitalar São João, Faculty of Medicine, Alameda Professor Hernani Monteiro, Porto, Portugal
(author)
-
Boesecke, ChristophDepartment of Medicine I, Bonn University, Bonn, Germany
(author)
-
Ustianowski, AndrewInfectious Diseases & Tropical Medicine and Research Lead, North Western Infectious Diseases Unit, Pennine Acute Hospitals NHS Trust, North Manchester General Hospital, Manchester, UK
(author)
-
Duberg, Ann-Sofi,1957-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases, Örebro University Hospital, Örebro, Sweden(Swepub:oru)adg
(author)
-
Ruta, SimonaStefan S. Nicolau Institute of Virology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
(author)
-
Salkic, Nermin N.Department of Gastroenterology and Hepatology, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina
(author)
-
Husa, PetrInfectious Diseases, Masaryk University, Brno, Czech Republic; Infectious Diseases, University Hospital Brno, Brno, Czech Republic
(author)
-
Lazarevic, IvanaInstitute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
(author)
-
Pineda, Juan A.Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain
(author)
-
Pshenichnaya, Natalia YurievnaRostov State Medical University, Rostov-on-Don, Russia
(author)
-
Tsertswadze, TengizInfectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia; Faculty of Medicine, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
(author)
-
Matičič, MojcaClinic for Infectious Diseases and Febrile Illnesses, University Medical Centre, Ljubljana, Slovenia
(author)
-
Puca, EdmondDepartment of Infection Diseases, University Hospital Center, Tirane, Albania
(author)
-
Abuova, GulzhanInfectious Diseases Department, South - Kazakhstan State Pharmaceutical Academy, Shymkent, Kazakhstan
(author)
-
Gervain, JuditDivision Hepato-Pancreatology, 1st Department of Gastroenterology and Molecular Diagnostic Laboratory, "Szent György" Teaching Hospital Székesfehérvár, Székesfehérvár, HungaryDivision Hepato-Pancreatology, 1st Department of Gastroenterology and Molecular Diagnostic Laboratory, "Szent György" Teaching Hospital Székesfehérvár, Székesfehérvár, Hungary
(author)
-
Bayramli, RaminDepartment of Microbiology and Immunology, Azerbaijan Medical University, Educational Therapeutic Hospital, Baku, Azerbaijan
(author)
-
Ahmeti, SalihInfectious Disease Clinic, University Clinical Centre of Kosova, Faculty of Medicine, Prishtina University, Pristina, Kosovo
(author)
-
Koulentaki, MairiDepartment of Gastroenterology, University Hospital of Heraklion, Heraklion, Crete, Greece
(author)
-
Kilani, BadreddineService des Maladies Infectieuses, Faculté de Médecine de Tunis, Université Tunis EL Manar, Hôpital la Rabta, Tunis, Tunisia
(author)
-
Vince, AdrianaUniversity Hospital of Infectious Diseases, Zagreb School of Medicine, Zagreb, Croatia
(author)
-
Negro, FrancescoDivisions of Gastroenterology and Hepatology of Clinical Pathology, University Hospital of Geneva, Geneva, Switzerland
(author)
-
Sunbul, MustafaDepartment of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University, Medical School, Samsun, Turkey
(author)
-
Salmon, DominiqueInfectious Diseases, Hôpitaux Universitaires Paris Centre, Université Paris Descartes, Paris, France
(author)
-
Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University, Medical School, Samsun, TurkeyInternal Medicine and Infectious Diseases, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands
(creator_code:org_t)
Related titles
-
In:Antiviral ResearchAmsterdam, Netherlands : Elsevier150, s. 9-140166-35421872-9096
Internet link
Find in a library
To the university's database
- By the author/editor
-
Leblebicioglu, H ...
-
Arends, Joop E.
-
Ozaras, Resat
-
Corti, Giampaolo
-
Santos, Lurdes
-
Boesecke, Christ ...
-
show more...
-
Ustianowski, And ...
-
Duberg, Ann-Sofi ...
-
Ruta, Simona
-
Salkic, Nermin N ...
-
Husa, Petr
-
Lazarevic, Ivana
-
Pineda, Juan A.
-
Pshenichnaya, Na ...
-
Tsertswadze, Ten ...
-
Matičič, Mojca
-
Puca, Edmond
-
Abuova, Gulzhan
-
Gervain, Judit
-
Bayramli, Ramin
-
Ahmeti, Salih
-
Koulentaki, Mair ...
-
Kilani, Badreddi ...
-
Vince, Adriana
-
Negro, Francesco
-
Sunbul, Mustafa
-
Salmon, Dominiqu ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Infectious Medic ...
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Pharmacology and ...
- Articles in the publication
-
Antiviral Resear ...
- By the university
-
Örebro University